Gail Jackson has extensive experience in the pharmaceutical sector, prominently at Sanofi Pasteur Limited, where contributions spanned from research to directorial roles in Quality Systems and Industrial CMC Compliance. From August 1985 until retirement in July 2019, Gail oversaw critical functions such as Annual Product Quality Review, Change Control, Corrective and Preventive Actions (CAPAs), and documentation management. Previously, Gail directed efforts in the Development Department to establish purification processes for bacterial and viral vaccines, alongside significant research on purification processes for various vaccine antigens. Educational background includes a BSc Honours in Biology and Chemistry and a PhD in Chemistry from the University of Waterloo.
This person is not in any teams
This person is not in any offices